• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9-β-D-阿拉伯呋喃糖基腺嘌呤掺入L1210 DNA与细胞毒性之间的关系。

Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.

作者信息

Kufe D W, Major P P, Munroe D, Egan M, Herrick D

出版信息

Cancer Res. 1983 May;43(5):2000-4.

PMID:6831429
Abstract

We have used cesium sulfate density gradient centrifugation to monitor the incorporation of 9-beta-D-arabinofuranosyladenine (ara-A) into L1210 cellular nucleic acids. The results demonstrate the specific incorporation of ara-A in L1210 DNA. We have also found a highly significant relationship between the formation of ara-A incorporated into DNA and loss of clonogenic survival. This relationship was maintained when using ara-A in the presence of the adenosine deaminase inhibitor deoxycoformycin. Furthermore, treatment with increasing concentrations of ara-A resulted in a greater proportion of ara-A residues at the 3'-terminus, consistent with this agent providing a poor primer terminus for elongating DNA strands. These findings are similar to those obtained previously with 1-beta-D-arabinofuranosylcytosine and suggest that the incorporation of arabinofuranosyl derivatives in DNA is one mechanism responsible for cell lethality.

摘要

我们使用硫酸铯密度梯度离心法来监测9-β-D-阿拉伯呋喃糖基腺嘌呤(ara-A)掺入L1210细胞核酸的情况。结果表明ara-A可特异性掺入L1210 DNA中。我们还发现,ara-A掺入DNA的形成与克隆形成存活率的丧失之间存在高度显著的关系。当在腺苷脱氨酶抑制剂脱氧助间型霉素存在的情况下使用ara-A时,这种关系得以维持。此外,用浓度不断增加的ara-A进行处理导致3'-末端的ara-A残基比例更高,这与该药物为延长DNA链提供不良引物末端一致。这些发现与先前用1-β-D-阿拉伯呋喃糖基胞嘧啶获得的结果相似,并表明阿拉伯呋喃糖基衍生物掺入DNA是导致细胞致死的一种机制。

相似文献

1
Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.9-β-D-阿拉伯呋喃糖基腺嘌呤掺入L1210 DNA与细胞毒性之间的关系。
Cancer Res. 1983 May;43(5):2000-4.
2
Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.1-β-D-阿拉伯呋喃糖基胞嘧啶掺入对真核生物DNA模板功能的影响。
Mol Pharmacol. 1984 Jul;26(1):128-34.
3
Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.2'-脱氧助间型霉素增强9-β-D-阿拉伯呋喃糖基腺嘌呤对小鼠白血病L1210细胞的体外细胞毒性。
Cancer Res. 1976 Apr;36(4):1486-91.
4
Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.2'-脱氧助间型霉素增强阿糖呋喃腺嘌呤的抗肿瘤活性。
Cancer Res. 1976 Apr;36(4):1481-5.
5
Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.将1-β-D-阿拉伯呋喃糖基胞嘧啶掺入对9-β-D-阿拉伯呋喃糖基腺嘌呤耐药的单纯疱疹病毒的DNA中。
Cancer Res. 1984 Jan;44(1):69-73.
6
Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤与9-β-D-阿拉伯呋喃糖基腺嘌呤对小鼠肿瘤细胞靶酶作用的比较。
Cancer Res. 1982 Jun;42(6):2260-4.
7
Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.培养的白血病L 1210细胞对9-β-D-阿拉伯呋喃糖基腺嘌呤的耐药性。
Cancer Res. 1983 Oct;43(10):4791-8.
8
Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤掺入HL-60细胞的RNA和DNA中。
Biochem Pharmacol. 1986 Jan 15;35(2):247-52. doi: 10.1016/0006-2952(86)90521-6.
9
1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.1-β-D-阿拉伯呋喃糖基胞嘧啶的代谢及其掺入DNA作为体内小鼠肿瘤细胞反应的决定因素。
Cancer Res. 1985 Dec;45(12 Pt 1):6244-9.
10
Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤对小鼠白血病L1210的代谢及化疗活性及其经脱氧胞苷激酶磷酸化的证据
Cancer Res. 1980 Oct;40(10):3610-5.

引用本文的文献

1
Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.6-巯基嘌呤与阿糖胞苷协同组合在人白血病细胞系中的细胞内药效学研究
Cancer Chemother Pharmacol. 1995;35(3):191-9. doi: 10.1007/BF00686547.
2
Arabinofuranosyl nucleosides induce common fragile sites.阿拉伯呋喃糖基核苷诱导常见脆性位点。
Hum Genet. 1988 Jun;79(2):157-62. doi: 10.1007/BF00280556.
3
Differential response of human and rodent cell lines to chemical inhibition of the repair of potentially lethal damage.
人类和啮齿动物细胞系对化学抑制潜在致死性损伤修复的差异反应。
Radiat Environ Biophys. 1989;28(3):193-202. doi: 10.1007/BF01211256.
4
Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.阿糖腺苷单磷酸、卡氮芥、威猛(依托泊苷)——治疗人类恶性脑肿瘤活性药物的体外比较研究
Br J Cancer. 1987 Feb;55(2):153-8. doi: 10.1038/bjc.1987.31.